arrow
F

Fabrice Carrat

institut national de la santé et de la recherche médicale (inserm)
H指数:83
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study
2025-12-010
OAAI
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis

肝硬度测量的预后价值与生化反应在原发性胆汁性胆管炎中的比较

2025-10-030
PRE
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012–2022

与法国2012–2022年因流感样疾病住院的成人中呼吸道合胞病毒和流感病毒感染相比的人类偏肺病毒感染特征

2025-07-160
OA
Symptoms and pathophysiology of post-acute sequelae following COVID-19 (PASC): a cohort study

COVID-19后急性期后遗症(PASC)的症状与病理生理学:一项队列研究

2025-05-300
PRE
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis

非侵入性检测动态在指导肝硬化患者HCV治愈后HCC监测决策中的价值

2025-02-260
PRE
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis

肝脏硬度测量的动力学和原发性胆汁性胆管炎的临床过程

2024-12-011
OAAI
Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study

双重单克隆抗体治疗新型冠状病毒肺炎进化的比较: 多中心回顾性研究

2024-09-290
OAAI
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave
2024-03-057
OAAI
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
2024-02-011
PRE